Comprehensive analysis of treatment-related adverse events of immunotherapy in advanced gastric or gastroesophageal junction cancer: A meta-analysis of randomized controlled trials

医学 荟萃分析 随机对照试验 内科学 不利影响 置信区间 系统回顾 子群分析 癌症 肿瘤科 梅德林 政治学 法学
作者
Hang Yuan,Dandan Duan,Yajun Zhang
出处
期刊:Clinics and Research in Hepatology and Gastroenterology [Elsevier BV]
卷期号:46 (10): 102031-102031 被引量:2
标识
DOI:10.1016/j.clinre.2022.102031
摘要

Immune checkpoint inhibitors (ICIs) have been recognized as an effective treatment for advanced gastric or gastroesophageal junction cancer (AG/GEJC). However, the safety of ICIs in patients has not been established. We aimed to systematically assess the risk of all common treatment-related adverse events (TRAEs) in immunotherapy of AG/GEJC.A systematic search of randomized controlled trials (RCTs) published until May 2022 was performed using PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials. And a meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.A total of nine RCTs, including 2918 patients, met the eligibility criteria. The pooled overall incidences of all grade TRAEs, grade 3 or higher TRAEs and treatment-related death were 54.5% (95% confidence interval [CI]: 48.7%-60.2%, I2=75.55%), 12.8% (95% CI: 10.2%-15.7%, I2=51.61%) and 0.11% (95% CI: 0.00%-0.51%, I2=1.63%). Subgroup analyses showed that CTLA-4 inhibitors had a higher risk of any type of TRAEs, when compared with PD-1 and PD-L1 inhibitors. Meta-regression showed significant correlation between all grade TRAEs and proportion of female. Fatigue and diarrhoea were involved in common TRAEs.Our study provides a comprehensive overview of ICIs-associated AEs in AG/GEJC. Immunotherapy did not have a significantly increased risk experiencing any type of TRAEs, and ICIs had a more manageable safety profile than chemotherapy. These findings provide important guidance to clinicians in counseling and management of patients with AG/GEJC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
伶俐芷波完成签到,获得积分10
2秒前
2秒前
2秒前
一秋一年发布了新的文献求助10
2秒前
2秒前
杨景瑶发布了新的文献求助10
2秒前
长歌且行完成签到,获得积分10
2秒前
2秒前
长情语蕊完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
琉璃苣发布了新的文献求助10
3秒前
3秒前
大个的应助被瘦瘦寄风采纳,获得10
4秒前
天天快乐的应助被黄鑫采纳,获得10
4秒前
娇气的友易完成签到,获得积分10
4秒前
Jun的应助被霁星河采纳,获得10
5秒前
5秒前
5秒前
5秒前
5秒前
1212完成签到,获得积分10
6秒前
豆奶粉或发布了新的文献求助10
6秒前
禹宛白发布了新的文献求助10
6秒前
6秒前
FashionBoy的应助被wzm采纳,获得10
6秒前
666发布了新的文献求助20
7秒前
xx2026发布了新的文献求助10
7秒前
王梦发布了新的文献求助10
7秒前
7秒前
7秒前
yzm发布了新的文献求助10
7秒前
瘦瘦白昼发布了新的文献求助10
7秒前
wry完成签到,获得积分10
8秒前
初(*^▽^*)心的应助被清脆慕山采纳,获得10
8秒前
zxw完成签到,获得积分10
8秒前
8秒前
逆麟发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162918
求助须知:如何正确求助?哪些是违规求助? 9557210
关于积分的说明 21738626
捐赠科研通 7753447
什么是DOI,文献DOI怎么找? 3427983
关于科研通互助平台的介绍 2552768
邀请新用户注册赠送积分活动 2472619